Financial Statement Release Q4 2023

Revenio Group Corporation’s Financial Statement Release 2023 was published on February 15, 2024. See result materials below.

Welcome to Revenio's investor website

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD).

Outlook and guidance

See our guidance

Next event

Annual General Meeting 2024 on April 4, 2024

Latest video

Investor contacts

CFO Robin Pulkkinen robin.pulkkinen(at)